Skip to content

Bain Capital Specialty Finance BCSF Investment Owned At Fair Value And Cash Equivalents Fair Value Disclosure

Investment Owned At Fair Value And Cash Equivalents Fair Value Disclosure at other companies

MidCap Financial Investment Corporation logo
MidCap Financial Investment CorporationMFIC
$2.97B-6.9%
Golub Capital logo
Golub CapitalGBDC
$8.4B-4.5%
Trinity Capital logo
Trinity CapitalTRIN
100%0.0pp
Trinity Capital logo
Trinity CapitalTRIN
$2.5B
MSD
Morgan StanleyMSDL
$3.87B
Goldman Sachs BDC logo
Goldman Sachs BDCGSBD
$3.23B-4.5%

Other financials

Income statement

See full
Net income$3.4M-88.1%
EPS (diluted)$0.05-88.6%

Balance sheet

See full
Cash & equivalents$13.0M+27.6%
Total debt$1.8B+0.2%
Total equity$1.1B-4.5%
Total assets$2.6B-1.5%

Cash flow

See full
Operating cash flow$26.6M+466%

Valuation

See full
Market cap$781.02M-19.3%
Enterprise value$2.52B-6.9%
P/E10.6×+2.0×

Returns & leverage

See full
Return on equity6.6%-3.3pp
Debt / equity1.6×+0.1×

Where this comes from

Reported directly by Bain Capital Specialty Finance in its filing.

Tagged under the XBRL concept bcsf:InvestmentOwnedAtFairValueAndCashEquivalentsFairValueDisclosure.

The official record: Bain Capital Specialty Finance’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bain Capital Specialty Finance's investment owned at fair value and cash equivalents fair value disclosure.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bain Capital Specialty Finance's investment owned at fair value and cash equivalents fair value disclosure?
Bain Capital Specialty Finance (BCSF) reported investment owned at fair value and cash equivalents fair value disclosure of $2.48B in Q1 2026.
What does investment owned at fair value and cash equivalents fair value disclosure mean?
This metric aggregates the current fair market value of all investment holdings and cash equivalents held by the company. It serves as the primary measure of the total net asset value available to shareholders at current market prices. Tracking this value is critical for assessing the overall performance and market valuation of the investment portfolio.